Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 25,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 25,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 22,310 | 14,817 | 16,532 | 12,070 | 13,995 |
| Operating Income | 2,690 | -14,817 | -16,532 | -12,070 | -13,995 |
| Other Income | 228 | 194 | 264 | 237 | 229 |
| Pre-tax Income | 2,918 | -14,623 | -16,268 | -11,833 | -13,766 |
| Net Income Continuous | 2,918 | -14,623 | -16,268 | -11,833 | -13,766 |
| Net Income | $2,918 | $-14,623 | $-16,268 | $-11,833 | $-13,766 |
| EPS Basic Total Ops | 2.40 | -12.40 | -13.80 | -10.00 | -11.80 |
| EPS Basic Continuous Ops | 2.48 | -12.46 | -13.87 | -10.09 | -11.74 |
| EPS Diluted Total Ops | 2.40 | -12.40 | -13.80 | -10.00 | -11.80 |
| EPS Diluted Continuous Ops | 2.45 | -12.46 | -13.87 | -10.09 | -11.74 |
| EBITDA(a) | $2,690 | $-14,817 | $-16,532 | $-12,070 | $-13,995 |